CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor

NCT02839954 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma
Non-small Cell Lung Cancer
Pancreatic Carcinoma
Triple-Negative Invasive Breast Carcinoma
Malignant Glioma of Brain
Colorectal Carcinoma
Gastric Carcinoma

Interventions

BIOLOGICAL: anti-MUC1 CAR-pNK cells

Sponsor

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Collaborators

[object Object]
[object Object]